Do Elevated Hematocrits Prolong the PT/aPTT?

The Clinical and Laboratory Standards Institute guidelines require special processing of whole blood specimens with hematocrits greater than 55% due to the possibility of spurious prolongation of routine coagulation studies (PT, aPTT). As samples with hematocrits above 60% are rare at our institutio...

Full description

Saved in:
Bibliographic Details
Published inClinical laboratory science Vol. 26; no. 2; pp. 89 - 94
Main Authors Austin, Melissa, Ferrell, Chris, Reyes, Morayma
Format Journal Article
LanguageEnglish
Published United States American Society for Clinical Laboratory Science 01.04.2013
Subjects
Adult
Blood tests
Citrates
Diagnostic Tests, Routine - standards
Hematocrit - standards
Hematology - standards
Human subjects
Humans
Partial Thromboplastin Time - standards
Phlebotomy
Plasma
Polycythemia - blood
Practolol
Prothrombin Time - standards
Sodium
Statistical significance
France
Online AccessGet full text

Cover

More Information
Summary:The Clinical and Laboratory Standards Institute guidelines require special processing of whole blood specimens with hematocrits greater than 55% due to the possibility of spurious prolongation of routine coagulation studies (PT, aPTT). As samples with hematocrits above 60% are rare at our institution, our study seeks to determine the effect of relative citrate excess on routine coagulation studies in samples with hematocrits of 60% to determine whether special processing is necessary. A calculated volume of 3.2% citrate was added to 1 mL aliquots of 40 whole blood samples in citrated tubes from adult patients to simulate a hematocrit of 60%. A dilutional control was created by adding an equivalent volume of saline to a separate 1 mL aliquot. Routine coagulation studies (PT, aPTT) were run on both samples on the STA Compact Analyzer in accordance with manufacturer instructions. While a paired Student's t-test demonstrated a clinically significant change in both PT and aPTT with the addition of citrate (p = 0.0002 for PT and p = 0.0234 for aPTT), clinical management would not have been altered by any observed change. More interestingly, we observed a shortening of 27/40 PTs and 23/40 aPTTs rather than the expected prolongation. Based on our data, no adjustment of citrate volume appears to be necessary in samples with hematocrits less than or equal to 60%.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-General Information-1
content type line 14
ObjectType-Feature-3
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:0894-959X
1945-3574
DOI:10.29074/ascls.26.2.89